Drug intelligence / Profile preview

TriCellPr-AC07

Development stage
Unknown
Lead developer
Aochen Biologics
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intraarticular
01

Overview

**TriCellPr-AC07** is an investigational, allogeneic human umbilical cord-derived mesenchymal stromal cell injection developed for knee osteoarthritis. The product is manufactured using a three-dimensional cell-culture process and is intended for local intra-articular administration. Its proposed therapeutic activity is regenerative and immunomodulatory: administered mesenchymal stromal cells may support cartilage repair and alter the inflammatory joint microenvironment through paracrine secretion of growth factors and anti-inflammatory mediators. The product received Chinese clinical-trial authorization for knee osteoarthritis in April 2025, and a registered early-phase study evaluates imaging-based tracking of SPIO-labeled administered cells in affected knee joints. ([aochen.bio](https://aochen.bio/blog-minimal2.html))

Other names
human umbilical cord-derived mesenchymal stromal cell injection

Beyond the preview

Go deeper on TriCellPr-AC07.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TriCellPr-AC07.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call